How dangerous are financial incentives to obtain organs?

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1337-1341

  Evans, R W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRUISM; CADAVER; COMMUNITY; CONFERENCE PAPER; COST; ECONOMIC ASPECT; ETHICS; GOVERNMENT; LIVING DONOR; MORALITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

HEALTH CARE AND PUBLIC HEALTH;

CADAVER; COSTS AND COST ANALYSIS; FEES AND CHARGES; HUMANS; MOTIVATION; ORGAN TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 0033026406     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)02019-3     Document Type: Conference Paper

References (92)

1. Evans R.W., Kitzmann D. Terasaki P.I., Cecka J.M. Clinical Transplants, 1996. 1997;UCLA Tissue Typing Laboratory, Los Angeles, Calif.
2. Hensley S. Mod Healthcare. 28:(15):1998;28.
3. Rovner J. Lancet. 351:1998;1041.
4. Stapleton S. Am Med News. 41:(11):1998;11.
5. Gardner J. Mod Healthcare. 28:(27):1998;9.
6. Shelton D.L. Am Med News. 41:(23):1998;32.
7. Rovner J. Lancet. 351:1998;1794.
8. Burdick J.F., Klein A.S., Harper A.M. Cecka J.M., Terasaki P.I. Clinical Transplants, 1996. 1997;322 UCLA Tissue Typing Laboratory, Los Angeles, Calif.
9. Fung J.J., Roberts J.P. Cecka J.M., Terasaki P.I. Clinical Transplants, 1996. 1997;325 UCLA Tissue Typing Laboratory, Los Angeles, Calif.
10. Shiffman M.L. Cecka J.M., Terasaki P.I. Clinical Transplants, 1996. 1997;333 UCLA Tissue Typing Laboratory, Los Angeles, Calif.
11. Semple N.M. Cecka J.M., Terasaki P.I. Clinical Transplants, 1996. 1997;335 UCLA Tissue Typing Laboratory, Los Angeles, Calif.
12. Warren J. Transplant News. 8:(12):1998;1.
13. Transplantation. 41:1986;1.
14. Gabriel R. Lancet. 337:1991;104.
15. Neph News Issues 12(5):15, 1991.
16. Prottas J.M. Transplantation. 53:1992;1371.
17. Childress J.F. UNOS Update. 8:(11):1992;8.
18. Murray T.H. Transpl Immun Lett. VIII:(I):1992;5.
19. Cohen L.R. Transpl Immun Lett. VIII:(I):1992;8.
20. Callender C.O. Transpl Immun Lett. VIII:(I):1992;9.
21. UNOS Update 9:9, 1993.
22. Bowden A.B., Hull A.R. Controversies in Organ Donation A Summary Report . 1993;National Kidney Foundation, New York.
23. Warren J. Transplant News. 2:(6):1992;1.
24. Kumar S. Lancet. 345:1995;376.
25. Siegel-Itzkovich J. Br Med J. 313:1996;1167.
26. Josefson D. Br Med J. 316:1998;725.
27. Sever M.S., Ecder T., Aydin A.E., et al. Nephrol Dial Transplant. 9:1994;350.
28. Evans R.W. N Engl J Med. 338:1998;1780.
29. Evans R.W., Orians C.E., Ascher N.L. JAMA. 267:1992;239.
30. Evans R.W. Transplant Proc. 24:1992;2152.
31. Evans R.W. Semin Nephrol. 12:1992;234.
32. Orians C.E., Evans R.W., Ascher N.L. Transplant Proc. 25:1993;1541.
33. Evans R.W. Rose E.A., Stevenson L.W. Management of End-Stage Heart Disease. 1997;Lippincott-Raven Press, Boston, Mass.
34. Sells R.A. J Med Ethics. 5:1979;165.
35. Caplan A.L. N Engl J Med. 311:1984;981.
36. Prottas J. JAMA. 260:1988;832.
37. Caplan A.L., Welvang P. Clin Transplant. 3:1989;170.
38. Gaber A.O., Hall G., Britt L.G. Transplant Proc. 22:1990;318.
39. Veatch R.M. N Engl J Med. 325:1991;1246.
40. Csillag C. Lancet. 347:1996;754.
41. Rich V. Lancet. 347:1996;754.
42. Kennedy I., Sells R.A., Daar A.S., et al. Lancet. 351:1998;1650.
43. Evans R.W. JAMA. 269:1993;3113.
44. Birenbaum A. Managed Care: Made In America. 1997;Praeger, Westport, Conn.
45. Grieson E.T. Do HMOs Cut Costs ... and Lives? 1997;Theresevision, Bensalem, Penn.
46. Friedman E. Health Aff. 16:(3):1997;174.
47. Ginzberg E. JAMA. 279:1998;501.
48. Kuttner R. N Engl J Med. 338:1998;1558.
49. Kuttner R. N Engl J Med. 338:1998;1635.
50. Friedman E. Health Forum J. 4:(4):1998;8.
51. Bellandi D. Mod Health. 28:(14):1998;3.
52. Evans R.W. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. Terasaki P.I., Cecka J.M. Clinical Transplants, 1993. 1994;359-391 UCLA Tissue Typing Laboratory, Los Angeles, CA.
53. Kindig D.A. Purchasing Population Health Paying for Results . 1997;University of Michigan Press, Ann Arbor, Mich.
54. Halverson P.K., Kaluzny A.D., McLaughlin C.P. Managed Care and Public Health. 1997;Aspen Publishers, Gaithersburg, Md.
55. Durch J.S., Bailey L.A., Stoto M.D. Improving Health in the Community A Role for Performance Monitoring . 1997;National Academy Press, Washington, DC.
56. Kindig D.A. Health Serv Res. 33:1998;223.
57. Mechanic D. Am J Public Health. 88:1998;874.
58. Schlesinger M., Gray B. Health Aff. 17:(3):1998;152.
59. Beaglehole R., Bonita R. Lancet. 351:1998;590.
60. Yach D., Bettcher D. Am J Public Health. 88:1998;735.
61. Yach D., Bettcher D. Am J Public Health. 88:1998;738.
62. Roemer M.I. Am J Public Health. 88:1998;744.
63. Jordan J., Dowswell T., Harrison S., et al. Br Med J. 316:1998;1668.
64. Statistical Abstract of the United States, 1997. 117th ed. Washington, DC: U.S. Bureau of the Census, 1997.
65. Fingerhut L.A., Warner M. Injury Chartbook. Health United States, 1996-97. DHHS Publication No (PHS) 97-1232. 1997;National Center for Health Statistics, Hyattsville, Md.
66. Evans R.W. Semin Anesthesiol. 14:1995;127.
67. Evans R.W. Liver Transplant Surg. 1:1995;61.
68. Evans R.W. Curr Opin Cardiol. 10:1995;169.
69. Hauboldt R.H. Cost Implications of Human Organ and Tissue Transplantation, An Update 1996 . 1996;Milliman & Robertson, Brookfield, Wisc.
70. Evans R.W., Kitzmann D.J. Clin Liver Dis. 1:1997;287.
71. Evans R.W., Kitzmann D.J. Surg Clin North Am. 78:1998;149.
72. Evans R.W. Lancet. 339:1992;185.
73. Zeckhauser R. Public Policy. 23:1975;419.
74. Card W.I., Mooney G.H. Br Med J. 2:1977;1627.
75. Roberts C.J., Farrow S.C., Charny M.C. Lancet. 1:1985;89.
76. Robinson J.C. Milbank Q. 64:1986;133.
77. Evans R.W. Valuing lives: an international dilemma. McAlpine J. Forum on Health Care: Where Do We Go From Here? 1991;27-29 The Medical-Legal Society of British Columbia, Vancouver, British Columbia.
78. Kleinig J. Valuing Life. 1991;Princeton University Press, Princeton, NJ.
79. Morrow R.H., Bryant J.H. Am J Public Health. 85:1995;1356.
80. Summerfield D. Lancet. 351:1998;1955.
81. Radcliffe-Richards J., Daar A.S., Guttman R.D., et al. Lancet. 351:1998;1950.
82. Benedict R. Patterns of Culture. 1934;Houghton-Mifflin, Boston, Mass.
83. Search VII(1):1, 1998.
84. Thomas L. The Lives of a Cell Notes of a Biology Watcher . 1974;Viking Press, New York.
85. Aston G. Am Med News. 40:(43):1997;6.
86. Davis K. Health Serv Res. 31:1997;641.
87. Blendon R.J., Benson J.M. Am J Public Health. 88:1998;345-346.
88. Altman S.H., Reinhardt U.E., Shields A.E. The Future US Healthcare System Who Will Care for the Poor and the Uninsured . 1998;Health Administration Press, Chicago, Ill.
89. Becker E. The Denial of Death. 1973;The Free Press, New York.
90. Vitez M. Final Choices Seeking the Good Death . 1997;Camino Books, Philadelphia, Penn.
91. Parkes C.M. Br Med J. 316:1998;1313.
92. Shane T.W. When Life Meets Death Stories of Death and Dying, Truth, and Courage . 1998;Haworth Press, Binghamton, NY.